Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment
This study has been completed.
Sponsor:
Chinese University of Hong Kong
Collaborator:
Hoffmann-La Roche
Information provided by:
Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT00226382
First received: September 23, 2005
Last updated: June 10, 2010
Last verified: October 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2008 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |